Evidence map›Paper›PMID 41912696›Full record

ReviewCell biology and toxicology2026

Regulation of m

Meng Wang, Yunxiu Wang, Zhiwei Cao, Zhaowei Gu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meng Wang *Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang City, 110004, Liaoning Province, People's Republic of China.
Yunxiu Wang *Department of Clinical Trial Ward, Clinical Trial and Conversion Center, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.
Zhiwei CaoDepartment of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang City, 110004, Liaoning Province, People's Republic of China.
Zhaowei GuDepartment of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang City, 110004, Liaoning Province, People's Republic of China. zwgu@cmu.edu.cn.

Funding

Natural Science Foundation of Liaoning Province 2024-MS-061Science and technology plan projects of Liaoning Province 2023 JH2/20200079
6 · The paper itself

Abstract

Th2-driven allergic responses are characterized by allergic reactions and immune dysregulation with complex pathogenesis that warrants urgent in-depth study. The predominant posttranscriptional modification observed in eukaryotic messenger RNAs, N6-methyladenosine (m

Indexed as

AdenosineHypersensitivityTh2 CellsAnimalsEpitranscriptomeHumansRNA, MessengerRNA MethylationAdenosineN-methyladenosineRNA, MessengerDiagnostics and therapeuticsImmune cellsImmune-related moleculesM6A modificationTh2-driven allergic responses

Identifiers

PMID41912696
PMCPMC13158254

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.